Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Gestational diabetes and health outcomes for mothers and babies

Official title: Understanding the Effects of Gestational Diabetes on Mother and Baby

Run by Medical University of Graz · NCT07459907 · Data updated 2026-11-12

This project will follow pregnant women with gestational diabetes to see how the condition affects mothers and their babies during pregnancy, delivery, and early postpartum.

More Pregnancy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment400 (estimated)
SponsorMedical University of Graz
Academic / other
Locations1 site (Graz)
StatusRecruiting
StartedJune 15, 2025
Main results expectedJune 2030
Study endsJune 2035
Registry record updatedApril 13, 2026
Trial IDNCT07459907 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pregnant women aged 18 years or older with an ongoing pregnancy before 32 weeks and a positive 75 g oral glucose tolerance test are ideal candidates.

Probably not a fit

Women diagnosed after the 32nd gestational week, pregnancies with major fetal anomalies, or those unwilling to attend study visits or provide samples are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center observational cohort will recruit pregnant women diagnosed with gestational diabetes after a positive 75 g oral glucose tolerance test, typically between gestational weeks 24 and 28. Participants will attend two study visits during pregnancy, provide clinical samples at delivery, and complete a postpartum visit 8–12 weeks after birth, with clinical data, physical measurements, questionnaires, and biological samples collected from mothers and infants. Approximately 100 women will be enrolled per year at the Department of Obstetrics and Gynecology of the Medical University of Graz, and women with major fetal anomalies or diagnosis after 32 weeks are excluded. The collected data and biosamples are intended for comprehensive phenotyping to help define mechanisms and early-life outcomes associated with gestational diabetes.

Why it matters

Potential benefit: If successful, the project could improve understanding of how gestational diabetes affects short- and long-term health and inform better prevention or follow-up strategies for mothers and children.

How similar studies have gone: Other longitudinal gestational diabetes cohorts have provided useful insights into maternal and offspring cardiometabolic risk, so this approach is established though mechanisms remain incompletely understood.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ongoing pregnancy prior to the 32nd gestational week and a positive GDM screening

Exclusion Criteria:

* gestational age 32nd gestational week
* fetal genetic anomalies /malformation

Where it's running

  • Department of Obstetrics and Gynecology, Medical University of Graz
    Graz, Austria
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.